3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
2
Neuroendocrine Tumors
2
Glioblastoma
2
Vaginal Neoplasms
1
Lymphoma, Follicular
1
Endometrial Serous Adenocarcinoma
1
Astrocytoma
1
Interventions
ruxolitinib
6
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Specimen Handling
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Injections
2
Cyclophosphamide
2
Busulfan
2
Biopsy
2
venetoclax
1
veliparib
1
piperine
1
pevonedistat
1
iadademstat
1
fludarabine
1
fedratinib
1
demethoxycurcumin
1
decitabine and cedazuridine drug combination
1
bomedemstat
1
Transplantation
1
Topotecan
1
Stem Cell Transplantation
1
Sirolimus
1
Resistance Training
1
Radiotherapy
1
N(4)-oleylcytosine arabinoside
1
Methotrexate
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thrombocythemia, Essential
×
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
×
90 days
×
Clear all
No trials found.